Master of Fate

While tracing the tricky and sometimes surprising paths of multipotent cells in the skin, mammary gland, and heart, Cédric Blanpain has repeatedly turned the stem cell field on its head.

Written byMegan Scudellari
| 9 min read

Register for free to listen to this article
Listen with Speechify
0:00
9:00
Share

CÉDRIC BLANPAIN
Professor of Stem Cell and Developmental Biology, Interdisciplinary Research Institute, Université Libre de Bruxelles - Brussels, Belgium
COURTESY OF CÉDRIC BLANPAIN
Cédric Blanpain is nothing if not dogged. During his first year of a 7-year medical school program at the Université Libre de Bruxelles (ULB) in Belgium, the 18-year-old did a rotation in a molecular biology lab and decided that he wanted a career in research. Yet, first, Blanpain finished his med school stint and completed a 2-year residency in internal medicine, though he never subsequently worked as a practicing physician.

“It was a lot of effort, being on call often and working 80 hours per week, while knowing that in the end I would never end up a general practitioner, but I wanted to finish what I started,” says Blanpain. In fact, he was so determined that even after completing a 4-year PhD, Blanpain went back to medicine for a year to get his board certification, which required returning to work in the intensive-care unit and riding along in ambulances to horrible accidents. “It was extremely stressful. It was awful, to be honest,” he admits.

Yet once his medical requirements were completed, Blanpain poured his tenaciousness into research, in 2002 starting a postdoc in the lab of Elaine Fuchs at Rockefeller University, one of the ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies